Duloxetine Hydrochloride
Product Images NDC 64725-1100

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Duloxetine Hydrochloride (NDC 64725-1100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Tya Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (64725 1100)

Label Image (64725 1100)
Duloxetine DR 30mg capsule is a prescription medication manufactured by Torrent and packaged by T.Y.A. Pharmaceuticals. The package contains 30 capsules and the lot number and expiration date are provided. Dosage instructions can be found in the package insert.*
FDA Label Image

Structure (Duloxetinedrcapsules Figure 01)

FDA Label Image

1 (Duloxetinedrcapsules Figure 02)

1 (Duloxetinedrcapsules Figure 02)
The text presents a chart showing the percentage of patients achieving pain relief with different dosages of Duloxetine and placebo. No other information is available.*
FDA Label Image

2 (Duloxetinedrcapsules Figure 03)

2 (Duloxetinedrcapsules Figure 03)
The text describes a chart labeled as "Figure 2" which depicts the percentage of patients achieving various levels of pain relief as measured by 24-hour average pain severity for Duloxetine 60 mg (twice daily), Duloxetine 60 mg (once daily), and a placebo.*
FDA Label Image

Graph (Duloxetinedrcapsules Figure 04)

FDA Label Image

Figure 6 (Duloxetinedrcapsules Figure 05)

FDA Label Image

Graph (Duloxetinedrcapsules Figure 06)

Graph (Duloxetinedrcapsules Figure 06)
The text is describing a graph that shows the percentage of patients who achieved various levels of pain relief using a placebo or Duloxetine at different doses. It is measuring the improvement in pain from baseline and showing the percent improvement for each treatment.*
FDA Label Image

Logo (Duloxetinedrcapsules Figure 07)

FDA Label Image

Logo (Duloxetinedrcapsules Figure 08)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.